Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
In Chapter 12 , we presented an overview of pharmacology during pregnancy; in this chapter, we focus on drugs specifically used to treat cardiac conditions in expecting mothers. These conditions include acute coronary syndromes and postoperative care (after angioplasty, stenting, or coronary bypass surgery), angina, arrhythmias, heart failure, and hypertension. The chapter concludes with a list of drugs commonly used to treat cardiac disease with recommendations for their use in breastfeeding mothers.
Note: Some drugs that are commonly used to treat patients with heart conditions should not be used during pregnancy in general. These include atenolol, which has been associated with fetal growth restriction when given in the first trimester; propafenone; and diltiazem, which, although it has been used safely in pregnancy, has caused embryopathy in animal studies. In most instances, verapamil can be used in place of diltiazem. In addition, angiotensin-converting enzymes (ACE) inhibitors and angiotensin receptor blockers (ARBs), both of which are mainstays in the treatment of systolic left-sided heart failure in nonpregnant patients, have been associated with fetal hypoperfusion, dysgenesis, and renal failure. They may be used postpartum.
Antiplatelet drugs are used to treat women with acute coronary syndromes and after angioplasty, stenting, or coronary bypass surgery. Often, aspirin is used throughout pregnancy to prevent preeclampsia, and it is generally considered safe during pregnancy. The safety of other antiplatelet drugs is not clearly established. A case of ticagrelor administration throughout pregnancy has been reported. The baby was small for gestational age, but the pregnancy was otherwise uneventful.
Drugs used to treat angina include nitroglycerin, isosorbide mononitrate, beta blockers, and verapamil.
Nitroglycerin SL (class B2) can be used safely, but it may lower maternal blood pressure. Isosorbide mononitrate is also generally safe to use in pregnancy (class B2), but it can lower maternal blood pressure in high doses. Beta blockers are effective in treating patients with angina and are generally safe; all are class C unless otherwise noted. There is considerable experience with metoprolol, propranolol, and labetalol. As already noted, atenolol (class D) should not be used in the first trimester because of concerns about fetal growth restriction. One may wish to use nadolol to treat channelopathies, but compared with other beta blockers, experience with this drug is limited. Verapamil (class C) can be used to treat patients with angina, and it also has been used extensively in pregnancy to treat patients with arrhythmias. It can be given both orally and intravenously. Amlodipine (class C) and nifedipine (class C) are other calcium channel blockers that may be used to treat patients with angina.
The pharmacological treatment of arrhythmias varies according to the specific condition: atrial fibrillation and atrial flutter, supraventricular tachycardia (SVT), and ventricular tachycardia (VT).
These arrhythmias usually require treatment with an atrioventricular (AV) nodal blocking agent to slow the rate. For acute situations, intravenous (IV) verapamil (class C) is the drug of choice. Long term, beta blockers such as metoprolol or oral verapamil (both class C) are best. Digoxin (class C) is not as effective and should be used only in rare situations when heart failure is present and beta blockers are ineffective or cannot be used. To prevent recurrences, an antiarrhythmic, such as flecainide (class C) or sotalol (class C), can be used; because both are proarrhythmic drugs, they should not be used in women with left ventricular dysfunction. In these cases, amiodarone (class D) is less likely to be proarrhythmic, but it should be used cautiously because of concerns for fetal thyroid dysfunction. Anticoagulation should be initiated. Acutely, IV heparin (class B) can be used; long term, low-molecular-weight heparin given subcutaneously (class B) is now the standard. In general, warfarin (class X) should not be used.
For the acute treatment of patients with SVT, IV adenosine (class C) is quite effective; it is the most commonly used treatment in both pregnant women and the general population. If adenosine fails or arrhythmias recur, IV verapamil (class C) can be used.
For long-term prevention of SVT recurrences, AV nodal blocking agents are the drugs of choice. Digoxin (class C) has been used for many years and is effective. The dose generally should be increased during pregnancy because of increased renal clearance. Beta blockers also are effective. Metoprolol (class C) is widely used, but propranolol (class C) or labetalol (class C) can be used as well. As noted earlier, atenolol (class D) has been associated with fetal growth restriction when given in the first trimester. The calcium channel blocker verapamil (class C) is also effective.
In the rare cases when an antiarrhythmic drug is needed, flecainide (class C) or sotalol (class C) can be used. Amiodarone (class D) is used in pregnancy to treat fetal tachycardia, but it should be used only as a last resort because of concerns for fetal thyroid dysfunction.
Idiopathic VT can be treated with beta blockers (class C) or verapamil (class C). If these drugs are unsuccessful, antiarrhythmics such as flecainide (class C) or sotalol (class C) could be tried. Amiodarone (class D) may be considered. However, it may not be necessary to eliminate all nonsustained VT.
Ventricular tachycardia associated with LV dysfunction is usually quite intermittent, and if the patient has an implantable cardioverter-defibrillator, it may not need to be treated. If there are recurrent episodes of VT, amiodarone (class D) is the best option.
Adenosine (class C), which is given intravenously, transiently blocks conduction through the AV node. It can be used diagnostically if the diagnosis of a tachycardia is uncertain. If the patient is in atrial flutter with two-to-one conduction, adenosine may bring out the flutter waves and allow a correct diagnosis. It also may be used as a diagnostic tool in wide complex tachycardias. SVT with aberrancy will usually break. Idiopathic VT may convert to sinus rhythm. Usually, adenosine has no effect on VT associated with structural heart disease.
Quinidine (class C) is rarely used today, but it may be a good option in extremely rare cases, such as VT storm in Brugada syndrome.
Pronestyl (class C) is still available for IV use and occasionally may be helpful in pregnant patients.
In current practice, lidocaine (class C) is rarely used in treating patients with ventricular arrhythmias; the lidocaine-like drug tocainamide has been used to treat idiopathic VT of pregnancy, but it is no longer available.
Heart failure can be classified as systolic or diastolic or as right or left sided, and the treatment varies for each.
To treat left-sided systolic heart failure, diuretics are used to relieve pulmonary congestion and edema, and beta blockers are used to help prevent recurrences. In nonpregnant patients, carvedilol is the most commonly used drug, but there is little experience with it in pregnancy, so metoprolol is probably the best choice. Digitalis can be used to treat symptoms. As noted earlier, ACE inhibitors and ARBs, both of which are mainstays of therapy in nonpregnant patients, should not be used.
To treat right-sided diastolic heart failure, diuretics are used. Beta blockers and verapamil are sometimes used, but there is little evidence that they are effective. Similarly, there is no convincing evidence that digitalis is helpful. Long-acting nitrates such as isosorbide dinitrate are also sometimes helpful in relieving symptoms.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here